[Reactivation of hepatitis B after cessation of Rituximab monotherapy].
Nancey
Stéphane
S
Moussata
Driffa
D
Tantin
Arnaud
A
Wassouf
Ahmad
A
Gadroy
François-Xavier
FX
Vial
Thierry
T
Claudel
Sylvette
S
Saurin
Jean-Christophe
JC
Flourie
Bernard
B
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006509:Hepatitis B / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab